Axiom Cloud Raises $7.4M Series A to Transform Commercial Refrigeration using AI

/

Axiom provides software-enabled services to major grocery chains and cold storage companies in hundreds of facilities across North America.

SAN JOSE, Calif., Jan. 18, 2023 /PRNewswire/ -- Axiom Cloud today announced its $7.4M Series A financing led by Blue Bear Capital. Following large-scale rollouts with major North American grocery chains and cold storage warehouse operators, Axiom raised its Series A to prepare for its next phase of growth. Axiom will use the funding to scale its software, operations, and sales teams to meet accelerating market demand for its refrigeration software. In total, Axiom Cloud has raised approximately $11.6M since its inception in 2020.

"We have followed Axiom Cloud's management for years and seen their refrigeration AI technology make an outsized impact, substantially lowering power use and refrigerant leaks, improving margins, and turning everyday cooling infrastructure into virtual batteries," said Ernst Sack, Partner at Blue Bear Capital and Board Director of Axiom Cloud. "2023 looks bright for companies like Axiom that can help staple retailers and supply chain companies lower cost, improve uptime, withstand labor shortages, and reduce their environmental footprint – all with an incredible ROI in the first year."

Click here for more….

1 big thing: Industry players unite to build trust in carbon storage

/

👀 First look: A half-dozen companies are unveiling a joint initiative this morning to help verify that carbon capture and sequestration (CCS) projects work as intended, Ben writes.

Driving the news: Environmental data and software firm Project Canary, Denbury Resources — which uses CO2 injections to boost oil recovery — and other partners announced joint work to support "third-party independent environmental assessments and data measurement."

Why it matters: Carefully tracking the performance of capture, transport and sequestration projects will get far more important if the tech reaches the scale needed to be a strong weapon against climate change.

How it works: Members of the new "collective" plan to harmonize existing frameworks and requirements into a measurement, verification and reporting system that's applicable to various industries.

Click here for more…..

Syndio Launches OppEQ Forecaster as Companies Look to Build Trust and Tackle the Next Transparency Wave

/

New feature helps companies forecast when they’ll hit representation goals based on current practices, and model scenarios to help achieve goals faster

As companies post salary ranges to comply with new laws, they are grappling with investor and employee demands for more transparency into diversity and opportunity. Against this backdrop, Syndio is expanding its groundbreaking OppEQ™ product with Forecaster, a new representation forecasting tool. OppEQ Representation, which launched at the beginning of the year, gave companies the ability to measure current demographic benchmarks against available talent, and develop meaningful diversity goals. Now, with Forecaster, companies can forecast when they’ll hit representation goals based on current practices and model different scenarios to see their impact on diversity trajectories.

Click here for more…..

SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options

/

Asset Management Ventures leads Series B and is joined by Bertelsmann and existing investors

AUSTIN, Texas, October 20, 2022--(BUSINESS WIRE)--SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, today announced a $35 million Series B funding round led by Asset Management Ventures, with participation from all existing investors, and joined by Bertelsmann. This new investment will accelerate the growth of SubjectWell's existing clinical trial patient recruitment efforts, expand its support of cancer research, and fund production of its awareness initiatives for post-approval treatments.

SubjectWell now partners with 16 of the top 20 pharmaceutical companies and has grown revenue by 800 percent over the past two years. And due to high demand from customers and the release of new service offerings, SubjectWell is poised to double revenue again in the next 12 months.

"Patient recruitment remains the largest choke point in clinical development – despite over $5B being spent annually. SubjectWell’s highly differentiated and scalable solution markedly reduces our clients’ enrollment timelines," said Ivor Clarke, CEO, SubjectWell. "SubjectWell expands access to clinical trials by engaging the 96 percent of the population that has never participated in clinical research – this approach allows us to engage a much more diverse patient population as we register 250,000 new patients per month."

Earlier this year, SubjectWell leveraged its expanding patient reach to begin recruiting for non-small cell lung cancer studies and has since added support for breast cancer trials.

Click here for more…..